These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15753528)

  • 1. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?
    Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I
    Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary diffuse gastric cancer: diagnosis and management.
    Blair V; Martin I; Shaw D; Winship I; Kerr D; Arnold J; Harawira P; McLeod M; Parry S; Charlton A; Findlay M; Cox B; Humar B; More H; Guilford P
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):262-75. PubMed ID: 16527687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
    Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
    J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone.
    Charlton A; Blair V; Shaw D; Parry S; Guilford P; Martin IG
    Gut; 2004 Jun; 53(6):814-20. PubMed ID: 15138207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
    Cisco RM; Norton JA
    Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.
    Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL
    Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
    Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
    Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
    Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies.
    Fujita H; Lennerz JK; Chung DC; Patel D; Deshpande V; Yoon SS; Lauwers GY
    Am J Surg Pathol; 2012 Nov; 36(11):1709-17. PubMed ID: 23073328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
    Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
    World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
    Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome.
    Friedman M; Adar T; Patel D; Lauwers GY; Yoon SS; Mullen JT; Chung DC
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):189-191. PubMed ID: 31678201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two independent families with strongly suspected hereditary diffuse gastric cancer based on the probands' endoscopic findings.
    Iwaizumi M; Yamada H; Fukue M; Maruyama Y; Sonoda A; Sugimoto M; Koda K; Kushima R; Maekawa M; Sugimura H
    Clin J Gastroenterol; 2020 Oct; 13(5):754-758. PubMed ID: 32594425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary diffuse gastric cancer].
    Sezeur A; Schielke A; Larue L; Fléjou JF
    Gastroenterol Clin Biol; 2006 Oct; 30(10):1205-13. PubMed ID: 17075480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.